27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Using Power Analysis to Choose the Unit of Randomization, Outcome, and Approach for Subgroup Analysis for a Multilevel Randomized Controlled Clinical Trial to Reduce Disparities in Cardiovascular Health

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We give examples of three features in the design of randomized controlled clinical trials which can increase power and thus decrease sample size and costs. We consider an example multilevel trial with several levels of clustering. For a fixed number of independent sampling units, we show that power can vary widely with the choice of the level of randomization. We demonstrate that power and interpretability can improve by testing a multivariate outcome rather than an unweighted composite outcome. Finally, we show that using a pooled analytic approach, which analyzes data for all subgroups in a single model, improves power for testing the intervention effect compared to a stratified analysis, which analyzes data for each subgroup in a separate model. The power results are computed for a proposed prevention research study. The trial plans to randomize adults to either telehealth (intervention) or in-person treatment (control) to reduce cardiovascular risk factors. The trial outcomes will be measures of the Essential Eight, a set of scores for cardiovascular health developed by the American Heart Association which can be combined into a single composite score. The proposed trial is a multilevel study, with outcomes measured on participants, participants treated by the same provider, providers nested within clinics, and clinics nested within hospitals. Investigators suspect that the intervention effect will be greater in rural participants, who live farther from clinics than urban participants. The results use published, exact analytic methods for power calculations with continuous outcomes. We provide example code for power analyses using validated software.

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s11121-024-01673-y.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association

          In 2010, the American Heart Association defined a novel construct of cardiovascular health to promote a paradigm shift from a focus solely on disease treatment to one inclusive of positive health promotion and preservation across the life course in populations and individuals. Extensive subsequent evidence has provided insights into strengths and limitations of the original approach to defining and quantifying cardiovascular health. In response, the American Heart Association convened a writing group to recommend enhancements and updates. The definition and quantification of each of the original metrics (Life’s Simple 7) were evaluated for responsiveness to interindividual variation and intraindividual change. New metrics were considered, and the age spectrum was expanded to include the entire life course. The foundational contexts of social determinants of health and psychological health were addressed as crucial factors in optimizing and preserving cardiovascular health. This presidential advisory introduces an enhanced approach to assessing cardiovascular health: Life’s Essential 8. The components of Life’s Essential 8 include diet (updated), physical activity, nicotine exposure (updated), sleep health (new), body mass index, blood lipids (updated), blood glucose (updated), and blood pressure. Each metric has a new scoring algorithm ranging from 0 to 100 points, allowing generation of a new composite cardiovascular health score (the unweighted average of all components) that also varies from 0 to 100 points. Methods for implementing cardiovascular health assessment and longitudinal monitoring are discussed, as are potential data sources and tools to promote widespread adoption in policy, public health, clinical, institutional, and community settings.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Random-Effects Models for Longitudinal Data

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Some Practical Guidelines for Effective Sample Size Determination

                Bookmark

                Author and article information

                Contributors
                KylieHarrall@ufl.edu
                Journal
                Prev Sci
                Prev Sci
                Prevention Science
                Springer US (New York )
                1389-4986
                1573-6695
                20 May 2024
                20 May 2024
                2024
                : 25
                : Suppl 3
                : 433-445
                Affiliations
                [1 ]Department of Health Outcomes and Biomedical Informatics, University of Florida College of Medicine, ( https://ror.org/02y3ad647) 2004 Mowry Road, Gainesville, 32606 FL USA
                [2 ]Department of Implementation Science, Wake Forest University School of Medicine, ( https://ror.org/0207ad724) 475 Vine Street, Winston-Salem, 27101 NC USA
                [3 ]Department of Pediatrics, University of Colorado School of Medicine, ( https://ror.org/04cqn7d42) 13123 E. 16th Ave., Aurora, 80045 CO USA
                Author information
                http://orcid.org/0000-0003-4467-2282
                Article
                1673
                10.1007/s11121-024-01673-y
                11239604
                38767783
                6522f184-df6e-4d9f-86a5-d11ba6da5f4b
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 11 March 2024
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000057, National Institute of General Medical Sciences;
                Award ID: 5R01GM121081-08
                Award ID: 3R25GM111901
                Award ID: 3R25GM111901-04S1
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000133, Agency for Healthcare Research and Quality;
                Award ID: R01HS028283
                Award Recipient :
                Categories
                Article
                Custom metadata
                © Society for Prevention Research 2024

                Medicine
                power,multilevel randomized controlled trial,composite outcome,subgroup analysis,heterogeneity of treatment effect

                Comments

                Comment on this article